To enhance the already comprehensive Crohn’s disease and ulcerative colitis treatment available at The Ohio State University Wexner Medical Center, the Division of Gastroenterology, Hepatology and Nutrition opened a dedicated, first-of-its-kind center for the treatment of inflammatory bowel disease (IBD) in November 2019. Under the leadership of internationally recognized medical director, Anita Afzali, MD, who is also an associate professor – clinical at the College of Medicine, this new multidisciplinary site, which houses one of the highest volume IBD centers in the region, provides convenient patient access to IBD treatment and services and enhances collaboration for clinical care and research.
Ohio State’s IBD Center offers:
- Diagnostic testing, from routine lab work and colonoscopies to advanced studies, including chromoendoscopy, balloon enteroscopy and video capsule endoscopy
- Tailored treatment plans, including the latest medication therapies designed to optimize symptom and disease management
- Collaborative visits with our IBD/colorectal surgeons
- Specialized programs such as Pediatric-to-Adult IBD Transition and Women’s Health
- All urgent IBD patient appointments within 1-3 days of referral
- More than 20 clinical trials in investigative drug therapies, diagnostics and nutrition
Ohio State’s new IBD Center further enhances our team’s ability to provide precision medicine and personalized care for every patient, helping individuals live healthier, more fulfilling lives.
Learn more about Ohio State’s Inflammatory Bowel Disease Center.